Independent Reviews: unintended consequences
Medians exaggerated In an oncology trial, whenever you’ve looked at a Kaplan Meier curve of a blinded, independent, central review (BICR)...
Fact or Fiction: PFS to OS is different in immuno-oncology
Whilst there are good reasons to believe this might be true, like all good statisticians I’m sceptical until I see some data. If the...
